Compare Stocks: MXCT, ADV, MAST, and ABM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABM ABM Industries	$47.86 -0.1%	$44.45	$36.96 ▼ $50.12	$2.80B	0.69	422,903 shs	550,229 shs
ADV Advantage Solutions	$39.24	$39.21	$12.23 ▼ $53.63	$521.89M	2.18	138,749 shs	62,518 shs
MXCT MaxCyte	$1.05	$1.19	$0.64 ▼ $2.19	$112.48M	1.48	1.00 million shs	478,634 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABM ABM Industries	0.00%	+0.36%	+8.35%	+16.73%	+5.32%
ADV Advantage Solutions	0.00%	+7.68%	+0.98%	+6.17%	+20.74%
MXCT MaxCyte	0.00%	-2.78%	-13.58%	+19.32%	-48.53%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABM ABM Industries	$47.86 -0.1%	$44.45	$36.96 ▼ $50.12	$2.80B	0.69	422,903 shs	550,229 shs
ADV Advantage Solutions	$39.24	$39.21	$12.23 ▼ $53.63	$521.89M	2.18	138,749 shs	62,518 shs
MXCT MaxCyte	$1.05	$1.19	$0.64 ▼ $2.19	$112.48M	1.48	1.00 million shs	478,634 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABM ABM Industries	0.00%	+0.36%	+8.35%	+16.73%	+5.32%
ADV Advantage Solutions	0.00%	+7.68%	+0.98%	+6.17%	+20.74%
MXCT MaxCyte	0.00%	-2.78%	-13.58%	+19.32%	-48.53%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABM ABM Industries	2.20	Hold	$47.00	-1.80% Downside
ADV Advantage Solutions	2.00	Hold	$34.38	-12.40% Downside
MXCT MaxCyte	2.00	Hold	$5.00	376.19% Upside

Current Analyst Ratings Breakdown

Latest MXCT, ADV, MAST, and ABM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/28/2026	MXCT MaxCyte	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/10/2026	MXCT MaxCyte	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/6/2026	ABM ABM Industries	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
6/24/2026	MXCT MaxCyte	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/8/2026	ABM ABM Industries	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$45.00 ➝ $48.00
5/7/2026	ADV Advantage Solutions	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$37.50 ➝ $50.00
5/6/2026	ADV Advantage Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/4/2026	ABM ABM Industries	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
5/4/2026	ADV Advantage Solutions	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold

(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABM ABM Industries	$8.75B	0.32	$5.24 per share	9.13	$29.16 per share	1.64
ADV Advantage Solutions	$3.54B	0.15	$14.17 per share	2.77	$42.42 per share	0.93
MXCT MaxCyte	$33.03M	3.41	N/A	N/A	$1.61 per share	0.65

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABM ABM Industries	$162.30M	$2.60	18.41	11.05	1.26	1.75%	11.84%	3.91%	9/3/2026 (Estimated)
ADV Advantage Solutions	-$227.74M	-$18.74	N/A	5.65	N/A	-6.78%	-37.22%	-7.93%	8/5/2026 (Estimated)
MXCT MaxCyte	-$44.63M	-$0.37	N/A	N/A	N/A	-121.16%	-20.03%	-17.14%	8/12/2026 (Estimated)

Latest MXCT, ADV, MAST, and ABM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	MXCT MaxCyte	-$0.12	N/A	N/A	N/A	$6.51 million	N/A
8/5/2026	Q2 2026	ADV Advantage Solutions	$1.51	N/A	N/A	N/A	$887.30 million	N/A
6/5/2026	Q2 2026	ABM ABM Industries	$0.92	$0.90	-$0.02	$0.73	$2.21 billion	$2.29 billion
5/12/2026	Q1 2026	MXCT MaxCyte	-$0.10	-$0.04	+$0.06	-$0.04	$7.28 million	$6.22 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABM ABM Industries	$1.16	2.42%	+7.45%	44.62%	59 Years
ADV Advantage Solutions	N/A	N/A	N/A	N/A	N/A
MXCT MaxCyte	N/A	N/A	N/A	N/A	N/A

Latest MXCT, ADV, MAST, and ABM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/4/2026	ABM ABM Industries	quarterly	$0.29	2.63%	7/2/2026	7/2/2026	8/3/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABM ABM Industries	1.04	1.46	1.46
ADV Advantage Solutions	3.18	1.95	1.95
MXCT MaxCyte	N/A	12.04	11.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABM ABM Industries	91.62%
ADV Advantage Solutions	49.82%
MXCT MaxCyte	68.81%

Insider Ownership

Company	Insider Ownership
ABM ABM Industries	0.90%
ADV Advantage Solutions	9.70%
MXCT MaxCyte	4.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABM ABM Industries	113,000	58.58 million	58.05 million	Optionable
ADV Advantage Solutions	73,000	13.30 million	12.01 million	Optionable
MXCT MaxCyte	80	107.12 million	102.73 million	Optionable

MXCT, ADV, MAST, and ABM Headlines

Recent News About These Companies

Brooklands Fund Management Ltd Invests $1.54 Million in MaxCyte, Inc. $MXCT

July 24, 2026 | marketbeat.com

MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance ...

July 21, 2026 | enidnews.comE

MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development

July 21, 2026 | globenewswire.com

MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026

July 15, 2026 | globenewswire.com

Short Interest in MaxCyte, Inc. (NASDAQ:MXCT) Drops By 64.3%

July 13, 2026 | marketbeat.com

MaxCyte Stock Short Interest Report | NASDAQ:MXCT | Benzinga

July 7, 2026 | benzinga.com

Analysts Offer Insights on Healthcare Companies: MaxCyte (MXCT) and Incyte (INCY)

June 12, 2026 | theglobeandmail.com

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and MaxCyte (MXCT)

June 4, 2026 | theglobeandmail.com

Here’s Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for Investors

May 13, 2026 | insidermonkey.com

MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript

May 13, 2026 | seekingalpha.com

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

May 12, 2026 | zacks.com

MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance

May 12, 2026 | globenewswire.com

MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026

April 29, 2026 | globenewswire.com

MaxCyte (MXCT) price target decreased by 11.67% to 4.33

April 10, 2026 | msn.com

MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 31, 2026 | globenewswire.com

MaxCyte (MXCT) Q4 2025 Earnings Call Transcript

March 26, 2026 | finance.yahoo.com

MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook

March 25, 2026 | seekingalpha.com

MaxCyte, Inc. (NASDAQ:MXCT) Q4 2025 Earnings Call Transcript

March 25, 2026 | insidermonkey.com

MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript

March 25, 2026 | seekingalpha.com

MaxCyte Inc (MXCT) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines Amid Strategic ...

March 25, 2026 | uk.finance.yahoo.com

MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates

March 24, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MXCT, ADV, MAST, and ABM Company Descriptions

ABM Industries NYSE:ABM

$47.86 -0.05 (-0.10%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$47.75 -0.11 (-0.24%)

As of 07/31/2026 07:34 PM Eastern

ABM Industries Incorporated, through its subsidiaries, engages in the provision of integrated facility, infrastructure, and mobility solutions in the United States and internationally. It operates through Business & Industry, Manufacturing & Distribution, Education, Aviation, and Technical Solutions segments. The company offers janitorial, facilities engineering, and parking services for commercial real estate properties, including corporate offices for high tech clients, sports and entertainment venues, and traditional hospitals and non-acute healthcare facilities; provides vehicle maintenance and other services to rental car providers. It also offers integrated facility services, engineering, and other specialized services in various types of manufacturing, distribution, and data center facilities. In addition, the company delivers custodial and landscaping and grounds for public school districts, private schools, colleges, and universities. Further, it supports airlines and airports with services comprising passenger assistance, catering logistics, air cabin maintenance, and transportation services. Additionally, the company provides electric vehicle power design, installation, and maintenance, as well as microgrid systems installations. ABM Industries Incorporated was founded in 1909 and is headquartered in New York, New York.

Advantage Solutions NASDAQ:ADV

$39.24 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$39.19 -0.05 (-0.13%)

As of 07/31/2026 07:34 PM Eastern

Advantage Solutions Inc. provides business solutions to consumer goods manufacturers and retailers in North America and internationally. It operates in two segments, Sales and Marketing. The Sales segment offers brand-centric services, such as headquarter relationship management; analytics, insights, and intelligence; and brand-centric merchandising services. This segment also provides retailer-centric services comprising retailer-centric merchandising and in-store media services. The Marketing segment offers brand-centric services, including shopper and consumer marketing, and brand experiential services; retailer-centric services, such as retail experiential and private label services; and digital marketing, and digital media and advertising services. The company was formerly known as Karman Holding Corp. and changed its name to Advantage Solutions Inc. in March 2016. The company was founded in 1987 and is headquartered in Irvine, California.

MaxCyte NASDAQ:MXCT

$1.05 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.05 0.00 (0.00%)

As of 07/31/2026 07:39 PM Eastern

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MXCT, ADV, MAST, and ABM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MXCT, ADV, MAST, and ABM Earnings

Compare Dividends

Latest MXCT, ADV, MAST, and ABM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MXCT, ADV, MAST, and ABM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MXCT, ADV, MAST, and ABM Company Descriptions

ABM Industries NYSE:ABM

Advantage Solutions NASDAQ:ADV

MaxCyte NASDAQ:MXCT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MXCT, ADV, MAST, and ABM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MXCT, ADV, MAST, and ABM Earnings

Compare Dividends

Latest MXCT, ADV, MAST, and ABM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MXCT, ADV, MAST, and ABM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MXCT, ADV, MAST, and ABM Company Descriptions

ABM Industries NYSE:ABM

Advantage Solutions NASDAQ:ADV

MaxCyte NASDAQ:MXCT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools